• Home
  • Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.

Author List
Eastham JA, Kelly WK, Grossfeld GD, Small EJ, Cancer and Leukemia Group B
Publication
Urology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1434892
Publication Year
2003
PubMed ID
14747042
Publication Title
Eastham JA, Kelly WK, Grossfeld GD, Small EJ, Cancer and Leukemia Group B. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology. 2003 Dec 29; 62 Suppl 1:55-62.